This compound was found to activate TrkB and TrkC receptors and enhance cholinergic neurite integrity in the basal forebrain in a mouse model of Alzheimer's disease, as evidenced by increased choline acetyltransferase (CHAT) presence (Gonzalez et al., 2022). This evidence concerns the gene NTRK2 and Alzheimer disease.